Our latest study explores patient confidence in interpreting ketone test results, DKA risk perceptions, and real-world testing behaviors in adults with type 1 Diabetes.
Our research finds Mounjaro patients report health benefits but face confusion and frustration during therapy initiation.
Our survey of 190 U.S. endocrinologists finds GLP-1 and SGLT2 prescribing at 90%+ and rising, while many patients resist starting basal insulin.
A dQ&A-CeQur study in Clinical Diabetes finds 2 months on the CeQur Simplicity insulin patch boosts patient satisfaction, cuts burden, and lifts well-being.
dQ&A research reveals primary care challenges in adopting diabetes tech, highlighting needs for CGM training, simpler tools, and better industry support.
This article reports results of a survey of patients and health care providers regarding their experiences of and challenges with the use of basal insulin.
Our European study explores Time in Range in diabetes, comparing outcomes and differences across six countries.
Philly De Piante recently presented dQ&A data on Advances in Disease-Modifying Interventions at the Global Congress on Cardiology. Watch the video here.
We're proud to share Evelyn Cox’s EASD 2022 abstract revealing mental-health disparities among Europeans with diabetes by nationality, gender, and age.
